The president's nominee to the Supreme Court brings with him a strong pro-business outlook, particularly in his willingness to restrict regulatory agencies, and his confirmation would be a seminal victory for corporate America in a decades-long campaign t
Analysis of EPA data highlights difficult balance between a company’s right to confidentiality and the public’s right to know about toxic chemicals
Initiatives to map gaps, challenges and prioritise further actions
New study on fluazinam’s neurotoxicity comes up with different findings from earlier report based on manufacturer’s data
: Two different groups want this valuable spectrum, but can they share?